Bo H. Kim

Goyang, Republic of Korea

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 261 publications

Korean Thyroid Association Guidelines on the Management of Differentiated Thyroid Cancers, Part II: Follow-up Surveillance after Initial Treatment 2026.

Korean Thyroid Association Guidelines on the Management of Differentiated Thyroid Cancers, Part II: Follow-up Surveillance after Initial Treatment 2026.

Journal: Endocrinology and metabolism (Seoul, Korea)

Published: May 27, 2026

KASL clinical practice guidelines for management of chronic hepatitis B Endorsed by the East Asia Liver Alliance (EALA).

KASL clinical practice guidelines for management of chronic hepatitis B Endorsed by the East Asia Liver Alliance (EALA).

Journal: Clinical and molecular hepatology

Published: May 09, 2026

Toward a future role for liver biopsy in HCC: literature evidence and survey-based perspectives from Korean experts.

Toward a future role for liver biopsy in HCC: literature evidence and survey-based perspectives from Korean experts.

Journal: Journal of liver cancer

Published: May 04, 2026

Risk of Intrahepatic and Extrahepatic Cancers in Hepatitis C Virus Infection: A Nationwide Cohort Study in Korea, 2005-2023.

Risk of Intrahepatic and Extrahepatic Cancers in Hepatitis C Virus Infection: A Nationwide Cohort Study in Korea, 2005-2023.

Journal: Liver international : official journal of the International Association for the Study of the Liver

Published: January 20, 2026

Thyroglobulin Cutoffs after Total Thyroidectomy Without Radioiodine in Low- to Intermediate-Risk Thyroid Cancer: A Multicenter Cohort Study.

Thyroglobulin Cutoffs after Total Thyroidectomy Without Radioiodine in Low- to Intermediate-Risk Thyroid Cancer: A Multicenter Cohort Study.

Journal: Thyroid : official journal of the American Thyroid Association

Published: December 30, 2025

Second-Line and Subsequent Therapies after Atezolizumab Plus Bevacizumab Treatment in Hepatocellular Carcinoma: A Multicenter Prospective Cohort Study.

Second-Line and Subsequent Therapies after Atezolizumab Plus Bevacizumab Treatment in Hepatocellular Carcinoma: A Multicenter Prospective Cohort Study.

Journal: Gut and liver

Published: October 29, 2025

Microneedle patch integrated with a pumpless microfluidic chip for heterologous drug delivery.

Microneedle patch integrated with a pumpless microfluidic chip for heterologous drug delivery.

Journal: Lab on a chip

Published: October 23, 2025

From Classification to Personalization: Advances in Thyroid Cancer Risk Stratification Systems.

From Classification to Personalization: Advances in Thyroid Cancer Risk Stratification Systems.

Journal: Endocrinology and metabolism (Seoul, Korea)

Published: October 04, 2025

Diagnostic Models for Predicting Follicular Thyroid Carcinomas Using Circulating Plasma MicroRNAs.

Diagnostic Models for Predicting Follicular Thyroid Carcinomas Using Circulating Plasma MicroRNAs.

Journal: Cancers

Published: September 30, 2025

Impact of the 2024 medical-policy conflict on hepatocellular carcinoma management in Korea.

Impact of the 2024 medical-policy conflict on hepatocellular carcinoma management in Korea.

Journal: Journal of liver cancer

Published: July 22, 2025

Efficacy and safety of pioglitazone versus dapagliflozin as an add-on to metformin and alogliptin combination therapy: the EPIDOTE study.

Efficacy and safety of pioglitazone versus dapagliflozin as an add-on to metformin and alogliptin combination therapy: the EPIDOTE study.

Journal: Scientific reports

Published: June 05, 2025

2025 Korean Thyroid Association Clinical Management Guideline on Active Surveillance for Low-Risk Papillary Thyroid Carcinoma.

2025 Korean Thyroid Association Clinical Management Guideline on Active Surveillance for Low-Risk Papillary Thyroid Carcinoma.

Journal: Endocrinology and metabolism (Seoul, Korea)

Published: May 17, 2025

Showing 1-12 of 261

Last Updated: 09/26/2026